Respiratory Diseases: Asthma And COPD Flashcards

1
Q

Define Childhood Asthma

A

Chronic disease associated with recurrent episodes of (reversible) airways obstruction manifesting as symptons of shortness of breath, wheeze and cough

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Describe the difference between a normal airway and one during asthma symptoms

A
  • Normal airway: outer layer is muscle within an inner airway wall, centre is open for airflow
  • Asthma airway: Outer layer is muscle within a thickened inner airway wall followed by mucus in the centre
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Describe the estimated asthma prevalence

A
  • > 10.1 in coastal countries (America, Canada, Brazil, Australia, UK)
  • 7.6-10.0 in South Africa, Finland etc
  • 5.1-7.5 in Iran, Saudi Arabia, France, Germany
  • 2.5-5.0 in Mexico, Morocco, Algeria, Pakistan, India
  • 0-2.5 in Russia, China
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Describe the temporal trends in asthma deaths and hospitalisations in Ecuador between 2000-2019

A
  • Hospitalisation rate drops slowly between 2001 and 2011 (24.5 - 22.5)
  • Sharper steady drop between 2011 and 2018 (22.5 - 14)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Describe the temporal trends in asthma deaths and hospitalisations in Ecuador between 2000-2019

A
  • Mortality rate was steadily dropping from 0.83 to 0.3 between 2000 and 2018
  • No more data beyond, possibly due to Covid 19
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Describe the world wide burden of asthma

A
  • 262 million people suffer from asthma worldwide (GBD, 2020).
    – 21.6 million DALYs in 2019
    – 460,000 asthma deaths in 2019.
    – Over 90% of all asthma deaths occur in low and lower-middle income countries.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

List the triggers of asthma

A
  • Exercise
  • Pets
  • Pollen
  • Bugs in the home
  • Chemical fumes
  • Dust
  • Smoke
  • Stress
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What else can cause asthma?

A
  • Dermatophagoides pteronyssinus
  • Blomia tropicalis
  • Mite faeces contain allergens: Der p1, Blo t5
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

List the risk factors for asthma

A
  • Parents with asthma (e.g. genetics)
  • Atopy
  • Childhood respiratory infections (e.g RHV and RSV)
  • Early life exposures to allergens or infections while the immune system is developing
  • Psychosocial stress, diet, etc
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How do we measure atopy in epidemiological studies?

A
  • Atopy
  • Either allergen Skin Prick Test reactivity (SPT)
  • Or allergen-specific IgE (asIgE)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the association between current wheeze with atopy?

A
  • Compare an allergen skin test reactivity with an allergen specific IgE
  • Measure the level of combined affluent and the combined non affluent
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Describe the difference between Asthmatic children with and without rhinovirus infection

A

VD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How does Asthma diagnosis work?

A
  • Based on:
  • Medical history
  • Physical examination
  • Test results:
  • Spirometry: Bronchial hyperresponsiveness, Reversibility
  • Blood: Eosinophilia, Specific IgE
  • Allergen skin prick test
  • Fractional Exhaled nitric oxide (FeNO)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How is asthma managed?

A
  • Medication: Quick relief (rescue) medications: Short acting beta agonists, Ipratropium (anticholinergic), Oral and intravenous corticosteroids
  • Long term control: Inhaled corticosteroids, Leukotriene modifiers, Long-acting beta agonists, Combination inhalers
  • Avoid triggers
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Describe the stepwise approach to asthma

A

VD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

List the issues of asthma in LMICs

A
  • Increasing burden of disease: Urbanisation and urban risk factors, inequalities
  • Access to healthcare and drugs: Under diagnosis/ poor training, use of ER for control, Affordable inhaled drugs, economic costs to family
  • Different risk factors and predominant non atopic disease
17
Q

Give another issue with asthma in LMICs

A

Urban residence is associated with a 50% greater risk of asthma than rural residence

18
Q

What is Pro-AR?

A

WHO Demonstration project - Bahia (Brazil)
Impact of a public health intervention for management
of severe asthma on health resource utilization and costs

19
Q

Describe the Programme for Control of Asthma in Bahia (ProAR)

A
  • Reference centre for management of severe asthma by a multidisciplinary team
  • Free treatment, according to guidelines
  • Research programme
  • A partnership between a public university (UFBA) and municipal health department
20
Q

What was the impact of ProAR on hospitalisation rates in the City of Salvador?

21
Q

Describe the costs of severe Asthma in Salvador Brazil

A
  • Year before: Government = $750 Families = $807
  • Year after: Government = $363 Families = $74
22
Q

What’s the linkage between Covid 19 and asthma?

A
  • Several respiratory viruses strongly linked to asthma attacks
  • COVID-19 does not appear to increase risk of asthma attacks
  • Some evidence that adult asthmatics with severe disease have greater risk of more severe Covid-19 outcomes.
  • ICS may protect against severe Covid-19 by reduction in airways inflammation and expression of ACE2
23
Q

Summarise this whole asthma section

A
  • Asthma is a common disease of childhood and adults
  • Airways obstruction reversible and generally associated with inflammation
    -May be allergic or non-allergic
  • Prevalence (was) increasing worldwide, now more in LMICs
  • Respiratory viral infections frequent cause of exacerbations
  • Spirometry important aid to diagnosis controlled by rescue (b2-agonist) and preventer (inhaled corticosteroids) medications
  • STEP-approach to management with increase or decrease in medications according to control of symptoms
  • Improved access to specialized care and treatment key to control in LMICs